FDA.reportPublic FDA data

Headache Relief

Product NDC
11673-247
11-digit product format
116730247
Labeler code
11673
Product ID
11673-247_76d94744-c471-4c6c-8894-5733d2df37ec
Type
HUMAN OTC DRUG
Nonproprietary name
Acetaminophen, Aspirin, Caffeine
Dosage form
TABLET
Route
ORAL
Labeler
TARGET Corporation
Application
part343
Marketing category
OTC MONOGRAPH NOT FINAL
Marketing start
2014-11-30
Marketing end
2020-11-30
Substance
ACETAMINOPHEN; ASPIRIN; CAFFEINE
Active strength
250 mg/1; mg/1; mg/1
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct11673-247DDiscontinued by firm2026-09-14
excluded packagepackage11673-24711673-247-10DDiscontinued by firm2026-09-14
excluded packagepackage11673-24711673-247-27DDiscontinued by firm2026-09-14

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 36 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage11673-247-27d630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage11673-247-10d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage11673-247-27f5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage11673-247-10f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage11673-247-272ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage11673-247-102ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage11673-247-27a1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage11673-247-10a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage11673-247-27cfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage11673-247-10cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage11673-247-27cdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage11673-247-10cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage11673-247-27302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage11673-247-10302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage11673-247-27ed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage11673-247-10ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage11673-247-270efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage11673-247-100efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage11673-247-27ad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage11673-247-10ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage11673-247-27367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage11673-247-10367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage11673-247-27557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage11673-247-10557ba5c1ecfa…9c80585c8c6e…

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ACETAMINOPHENACTIVE INGREDIENT362O9ITL9DHEADACHE RELIEF (ACETAMINOPHEN, ASPIRIN, CAFFEINE) TABLET [TARGET CORPORATION]1
ASPIRINACTIVE INGREDIENTR16CO5Y76EHEADACHE RELIEF (ACETAMINOPHEN, ASPIRIN, CAFFEINE) TABLET [TARGET CORPORATION]1
CAFFEINEACTIVE INGREDIENT3G6A5W338EHEADACHE RELIEF (ACETAMINOPHEN, ASPIRIN, CAFFEINE) TABLET [TARGET CORPORATION]1
ACETAMINOPHENACTIVE MOIETY362O9ITL9DHEADACHE RELIEF (ACETAMINOPHEN, ASPIRIN, CAFFEINE) TABLET [TARGET CORPORATION]1
ASPIRINACTIVE MOIETYR16CO5Y76EHEADACHE RELIEF (ACETAMINOPHEN, ASPIRIN, CAFFEINE) TABLET [TARGET CORPORATION]1
CAFFEINEACTIVE MOIETY3G6A5W338EHEADACHE RELIEF (ACETAMINOPHEN, ASPIRIN, CAFFEINE) TABLET [TARGET CORPORATION]1
C10-18 TRIGLYCERIDESINACTIVE INGREDIENT43AGM4PHPIHEADACHE RELIEF (ACETAMINOPHEN, ASPIRIN, CAFFEINE) TABLET [TARGET CORPORATION]1
CARNAUBA WAXINACTIVE INGREDIENTR12CBM0EIZHEADACHE RELIEF (ACETAMINOPHEN, ASPIRIN, CAFFEINE) TABLET [TARGET CORPORATION]1
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UHEADACHE RELIEF (ACETAMINOPHEN, ASPIRIN, CAFFEINE) TABLET [TARGET CORPORATION]1
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WOHEADACHE RELIEF (ACETAMINOPHEN, ASPIRIN, CAFFEINE) TABLET [TARGET CORPORATION]1
MALTODEXTRININACTIVE INGREDIENT7CVR7L4A2DHEADACHE RELIEF (ACETAMINOPHEN, ASPIRIN, CAFFEINE) TABLET [TARGET CORPORATION]1
MINERAL OILINACTIVE INGREDIENTT5L8T28FGPHEADACHE RELIEF (ACETAMINOPHEN, ASPIRIN, CAFFEINE) TABLET [TARGET CORPORATION]1
POLYDEXTROSEINACTIVE INGREDIENTVH2XOU12IEHEADACHE RELIEF (ACETAMINOPHEN, ASPIRIN, CAFFEINE) TABLET [TARGET CORPORATION]1
POVIDONESINACTIVE INGREDIENTFZ989GH94EHEADACHE RELIEF (ACETAMINOPHEN, ASPIRIN, CAFFEINE) TABLET [TARGET CORPORATION]1
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4HEADACHE RELIEF (ACETAMINOPHEN, ASPIRIN, CAFFEINE) TABLET [TARGET CORPORATION]1
SODIUM STARCH GLYCOLATE TYPE A CORNINACTIVE INGREDIENTAG9B65PV6BHEADACHE RELIEF (ACETAMINOPHEN, ASPIRIN, CAFFEINE) TABLET [TARGET CORPORATION]1
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJHEADACHE RELIEF (ACETAMINOPHEN, ASPIRIN, CAFFEINE) TABLET [TARGET CORPORATION]1
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APHEADACHE RELIEF (ACETAMINOPHEN, ASPIRIN, CAFFEINE) TABLET [TARGET CORPORATION]1
TALCINACTIVE INGREDIENT7SEV7J4R1UHEADACHE RELIEF (ACETAMINOPHEN, ASPIRIN, CAFFEINE) TABLET [TARGET CORPORATION]1
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPHEADACHE RELIEF (ACETAMINOPHEN, ASPIRIN, CAFFEINE) TABLET [TARGET CORPORATION]1